论文部分内容阅读
目的:对比观察多索茶碱与氨茶碱治疗支气管哮喘的临床疗效。方法:将我院2013年8月~2014年8月108例支气管哮喘患者为本次研究对象,按随机原则将全部患者分别归为观察组和对照组,各54例。观察组患者采用多索茶碱治疗,对照组患者采用氨茶碱治疗。经7d连续治疗后,对患者的不良反应和和治疗效果进行比较。结果:治疗后,观察组患者的不良反应发生率为3.7%,治疗总有效率为92.59%;对照组不良反应发生率为12.96%,治疗总有效率为77.78%。两组患者比较结果显示,观察组患者明显优于对照组,具有统计学意义(p<0.05)。结论:相比氨茶碱治疗,使用多索茶碱治疗支气管哮喘患者具有更加显著的疗效,也更能有效地减低不良反应的发生率,该药物的使用不仅有效且安全性极高,具有较高的临床价值,应积极在临床中应用和推广。
Objective: To compare the clinical efficacy of doxofylline and aminophylline in the treatment of bronchial asthma. Methods: 108 patients with bronchial asthma in our hospital from August 2013 to August 2014 were selected as the study subjects. All patients were randomly divided into observation group and control group, with 54 cases in each group. Patients in the observation group were treated with doxofylline, and patients in the control group were treated with aminophylline. After 7 days of continuous treatment, adverse reactions to the patient and compared with the treatment. Results: After treatment, the incidence of adverse reactions in the observation group was 3.7% and the total effective rate was 92.59%. The incidence of adverse reactions in the control group was 12.96% and the total effective rate was 77.78%. Comparison of the two groups of patients showed that the observation group was significantly better than the control group, with statistical significance (p <0.05). CONCLUSIONS: Compared with aminophylline treatment, the use of doxofylline in the treatment of patients with bronchial asthma has a more significant effect, but also more effectively reduce the incidence of adverse reactions, the use of the drug is not only effective and highly safe, with more High clinical value, should be actively applied in clinical and promotion.